Key result
Consensus targets SBP 120 for low syncope risk but higher goals for frail or elderly patients.
Why the study?
The management of hypertensive patients with syncope requires balancing cardiovascular and hypotensive risks to optimize blood pressure reduction without drug-related fainting.
Individualizing systolic blood pressure targets based on a patient's syncope risk, cardiovascular risk, age, and frailty status can optimize cardiovascular prevention while minimizing the risk of drug-induced hypotension and falls.
Answers are grounded in this paper and cite their sources.
Supports risk-stratified SBP targets in syncope-prone or frail patients; leaves open prospective RCTs for outcome confirmation.
The management of a hypertensive patient with a history of syncope is aimed at maintaining a balance between cardiovascular and hypotensive (syncope) risks. The article presents an analysis of the literature data regarding the relationship between these clinical problems, and also draws practical conclusions that allow to ensure the optimal reduction in blood pressure in the interests of preventing cardiovascular diseases without the threat of drug-related hypotension (fainting). Variants of syncope in patients with arterial hypertension are summarized, depending on the association with antihypertensive therapy. There presented an expert opinion on the recommended target level of systolic blood pressure (120 mm Hg) in hypertensive patients under 70 years of age with a low syncope but high cardiovascular risk, as well as the target level of systolic blood pressure (140 mm Hg) in patients with high syncope and low cardiovascular risk or in elderly and / or frail individuals with hypertension. There noted the admissibility of bringing the systolic blood pressure to the target value up to 160 mm Hg in persons with severe frailty or disability. Examples of normal and pathological (hypotensive) patterns of hemodynamic response in persons with hypertension to long-term passive orthostasis obtained during the tilt test and influencing the decision-making on the activity of antihypertensive therapy are given. The importance of an interdisciplinary team approach with the participation of experts in regulatory circulatory disorders and geriatrics, which can significantly improve the quality of management of patients with a combination of hypertension and syncope, is stated.
No takes yet. Share an insight, caveat, or question.
Барсуков et al. (2021) conducted a review in Arterial hypertension and syncope. Antihypertensive therapy (blood pressure targets) was evaluated. Expert consensus recommends a target systolic blood pressure of 120 mm Hg for patients under 70 with low syncope risk, and 140-160 mm Hg for those with high syncope risk, elderly, or frail individuals.
Synapse has enriched 10 related papers. Consider them for comparative context: